Synthesis and biological evaluation of quinoline/cinnamic acid hybrids as amyloid-beta aggregation inhibitors
- 12 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Monatshefte für Chemie / Chemical Monthly
- Vol. 151 (5), 845-852
- https://doi.org/10.1007/s00706-020-02609-2
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (21672082)
- Natural Science Foundation of Shandong Province (ZR2019YQ31, ZR2017BC101)
- Shandong Talents Team Cultivation Plan of University Preponderant Discipline (10027)
This publication has 42 references indexed in Scilit:
- Repurposing of Nitroxoline Drug for the Prevention of NeurodegenerationChemical Research in Toxicology, 2019
- Quinoline Fluorescent Probes for Zinc - from Diagnostic to Therapeutic Molecules in Treating Neurodegenerative DiseasesMedicinal Chemistry, 2017
- Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesteraseBioorganic Chemistry, 2017
- Amyloid beta: structure, biology and structure-based therapeutic developmentActa Pharmacologica Sinica, 2017
- Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult MiceMolecular Neurobiology, 2016
- Optimizing the Diagnosis of Early Alzheimer's Disease in Mild Cognitive Impairment SubjectsJournal of Alzheimer's Disease, 2012
- Structural Diversity of Amyloid OligomersBiophysical Journal, 2010
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Therapeutic approaches to Alzheimer’s diseaseCurrent Opinion in Chemical Biology, 2000
- Amyloid β interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's diseaseNature Neuroscience, 2000